PDCD1 and non-small cell lung carcinoma: Further evaluation on how the initiation time of antibiotic treatment impact patient outcomes was done by Pinato et al.78 Broad-spectrum antibiotics were given to 29 and 68 patients (malignant melanoma or NSCLC) 30 d before or during anti-PD-1/PD-L1 therapy, respectively.